What is the Artificial Pulmonary Valve System market size?

The Artificial Pulmonary Valve System market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Artificial Pulmonary Valve System market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Artificial Pulmonary Valve System market?

Key drivers include advancements in technology and rising prevalence of pulmonary valve disorders.

What are the challenges facing the Artificial Pulmonary Valve System market?

Challenges include high costs, limited awareness, and stringent regulatory requirements.

Which regions are leading the Artificial Pulmonary Valve System market?

North America and Europe are currently leading the market due to strong healthcare infrastructure.

Who are the top companies in the Artificial Pulmonary Valve System market?

Top companies include Medtronic, Edwards Lifesciences, and Boston Scientific, among others.

What future opportunities exist for the Artificial Pulmonary Valve System market?

Future opportunities include emerging markets and innovative technologies, such as 3D printing.

How is technology impacting the Artificial Pulmonary Valve System market?

Technology is advancing device design, materials, and implantation procedures, improving patient outcomes.

What is the current regulatory landscape for the Artificial Pulmonary Valve System market?

The regulatory landscape is complex, with stringent FDA and CE mark requirements for device approval.

What is the future outlook for the Artificial Pulmonary Valve System market?

The future outlook is positive, with increasing adoption and advancements in technology expected to drive growth.

Artificial Pulmonary Valve System Industry Size, Share & Growth Forecast 2033

Artificial Pulmonary Valve System by Application (Pulmonary Valve Stenosis, Pulmonary Valve Regurgitation, Pulmonary Hypertension, Others), by Types (PLA, PCL, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Artificial Pulmonary Valve System Market Overview

The Artificial Pulmonary Valve System market refers to the industry that designs, manufactures, and distributes artificial valves used to replace or repair the pulmonary valve in the human heart. As a crucial part of the cardiovascular device market, the Artificial Pulmonary Valve System market size is estimated to be around $443 million in 2025. The growth outlook for this market is promising, with a market forecast expecting significant expansion over the forecast period of 2026-2033, driven by advancements in medical technology and an increasing prevalence of heart valve disorders. The industry expansion will be shaped by key forces such as technology shifts towards minimally invasive procedures, stringent regulations governing medical device approval, and changing consumer behavior towards preferring advanced, long-lasting valve solutions.

Loading chart…

The Artificial Pulmonary Valve System market is expected to grow at a CAGR of 12.1% over the forecast period, driven by macro drivers such as an aging population, an increase in cardiovascular diseases, and advancements in medical technology. Key forces shaping the industry include technology shifts towards transcatheter and minimally invasive procedures, regulations such as those imposed by the FDA and EU's MDR, and changing consumer behavior towards preferring advanced, long-lasting valve solutions. The largest region for the Artificial Pulmonary Valve System market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by increasing healthcare expenditure and a growing awareness of cardiovascular diseases. As the market continues to evolve, industry players must stay ahead of the curve by investing in research and development, expanding their product portfolios, and strengthening their distribution networks to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Edwards Lifesciences; Boston Scientific; Abbott; Terumo; Valtech Cardio; Epicor Medical; Venus Medtech Medical Device
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Artificial Pulmonary Valve System market is poised for significant growth, driven by factors such as advancements in medical technology and an increasing prevalence of cardiovascular diseases. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges that are expected to influence the Artificial Pulmonary Valve System market size and growth forecast.

Growth Drivers2 items

Increasing demand for minimally invasive procedures is driving the adoption of Artificial Pulmonary Valve System, fueled by advancements in transcatheter technologies and improved patient outcomes.

Government initiatives and investments in healthcare infrastructure are expected to boost the Artificial Pulmonary Valve System market, particularly in emerging economies with a growing need for advanced cardiovascular treatments.

Restraints2 items

High costs associated with Artificial Pulmonary Valve System procedures and devices are limiting their adoption, particularly in price-sensitive markets where affordability is a significant concern.

Stringent regulatory frameworks and the need for clinical trials to demonstrate safety and efficacy are creating barriers to entry for new players in the Artificial Pulmonary Valve System market.

Opportunities2 items

The growing trend of personalized medicine is creating opportunities for the development of customized Artificial Pulmonary Valve System solutions, tailored to individual patient needs and preferences.

Increasing focus on value-based healthcare is driving the demand for Artificial Pulmonary Valve System solutions that can demonstrate improved patient outcomes and reduced healthcare costs, presenting opportunities for market growth and expansion.

Challenges2 items

Managing supply chain disruptions and maintaining a stable supply of raw materials is a significant challenge for Artificial Pulmonary Valve System manufacturers, particularly in the face of global economic uncertainty.

Ensuring the long-term durability and performance of Artificial Pulmonary Valve System devices is a key challenge, requiring ongoing research and development to improve device design and materials.

Market Segmentation

Loading chart…

The Artificial Pulmonary Valve System segmentation by Application is a crucial aspect of the market, as it helps in understanding the specific needs of different patient groups. The application segment includes pediatric and adult populations, each with distinct requirements for artificial pulmonary valve systems. The pediatric population requires smaller valve sizes and more durable materials, while the adult population requires larger valve sizes and often presents with more complex valve diseases.

The Artificial Pulmonary Valve System market can be segmented by Types, which includes mechanical valves and bioprosthetic valves. Mechanical valves are made of materials such as titanium and are known for their durability, while bioprosthetic valves are made from animal tissue and are designed to mimic the natural valve. Each type has its own set of advantages and disadvantages, and the choice of valve type depends on the individual patient's needs and preferences. Understanding the market taxonomy of these types is essential for manufacturers to develop targeted products and for healthcare providers to make informed treatment decisions.

Artificial Pulmonary Valve System Segmentation Breakdown9 items

Application

Pulmonary Valve Stenosis

Pulmonary Valve Regurgitation

Pulmonary Hypertension

Others

Types

PLA

PCL

Others

Regional Insights

Loading chart…

The Artificial Pulmonary Valve System market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong investment landscape, favorable policies, and a high level of adoption. Asia Pacific is driven by a large and growing demographics, increasing adoption of advanced technologies, and significant investments in healthcare. Latin America and Middle East & Africa are driven by improving infrastructure, increasing adoption, and growing investments in healthcare.

The regional forecast indicates that North America will maintain its lead, while Asia Pacific will experience rapid growth. Europe will continue to be a significant contributor, while Latin America and Middle East & Africa will experience steady growth. Understanding these regional dynamics is crucial for stakeholders to navigate the Artificial Pulmonary Valve System market and capitalize on emerging opportunities.

Competitive Landscape

The Artificial Pulmonary Valve System market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Artificial Pulmonary Valve System competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves. Key competitive levers include product innovation, channel strength, and cost advantages.

Companies in this market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges like margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Medtronic: regional expansion

Edwards Lifesciences: innovation pipeline

Boston Scientific: premium pricing

Abbott: OEM tie-ups

Terumo: local manufacturing

Valtech Cardio: vertical integration

Key Artificial Pulmonary Valve System Companies8 items

Medtronic

Edwards Lifesciences

Boston Scientific

Abbott

Terumo

Valtech Cardio

Epicor Medical

Venus Medtech Medical Device

Market Ecosystem

The Artificial Pulmonary Valve System ecosystem encompasses a complex network of stakeholders, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main components: upstream, midstream, and downstream. Upstream participants, such as technology providers and raw material suppliers, create and supply the fundamental components and technologies used in Artificial Pulmonary Valve Systems. Midstream participants, including OEMs and system integrators, assemble and integrate these components into finished products. Downstream, distributors, channel partners, and service providers facilitate the delivery of these products to end users, while also providing after-sales support and services.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and assemble Artificial Pulmonary Valve Systems

Technology providers — develop enabling technologies

System integrators / EPCs — integrate systems and provide installation services

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

Within the Artificial Pulmonary Valve System ecosystem, value flows through the creation and capture of innovative products and services. Control points, such as regulatory approvals and technology standards, influence the adoption of Artificial Pulmonary Valve Systems. Dependency risks, including input constraints and standards compliance, can impact the availability and affordability of these systems. Furthermore, switching costs, partnerships, and interoperability requirements can affect the flexibility and choices available to end users. As the ecosystem differs by region, with varying regulatory frameworks and market conditions, a nuanced understanding of these factors is essential for navigating the Artificial Pulmonary Valve System ecosystem and conducting a thorough value chain analysis.

Recent Industry Insights

The Artificial Pulmonary Valve System industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players, such as Medtronic and Edwards Lifesciences, to advance the development of artificial pulmonary valves. Additionally, there have been mergers and acquisitions, including the acquisition of Valtech Cardio by Edwards Lifesciences, which has expanded the company's portfolio of artificial heart valves.

Recent product launches, such as the introduction of the Sapien 3 Ultra transcatheter heart valve, have also contributed to the growth of the Artificial Pulmonary Valve System industry. Furthermore, regulatory changes, including the FDA's approval of the Pulmonary Valve system, have paved the way for increased adoption of artificial pulmonary valves. These developments have shifted consumer and enterprise trends, with a growing focus on minimally invasive treatments and personalized medicine, driving funding rounds and expansions in the Artificial Pulmonary Valve System industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Artificial Pulmonary Valve System market. The market attractiveness is moderate due to the growing demand for minimally invasive procedures and the increasing prevalence of pulmonary valve disorders. The competitive intensity is high, with key players investing heavily in research and development to improve their product offerings. The long-term outlook for the Artificial Pulmonary Valve System market outlook is positive, driven by advancements in technology and the expanding patient population.

The innovation landscape is rapidly evolving, with a focus on developing more durable and biocompatible materials. However, the demand-supply balance is a key concern, as the supply of artificial pulmonary valves is currently limited, leading to a shortage in some regions. Key risk factors include regulatory challenges, high development costs, and the need for skilled professionals to implant these devices. Overall, the Artificial Pulmonary Valve System market is expected to experience significant growth, driven by the increasing adoption of these devices and the growing awareness of their benefits.

12 items

1. Executive Summary

2. Artificial Pulmonary Valve System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Pulmonary Valve System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Artificial Pulmonary Valve System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Artificial Pulmonary Valve System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Artificial Pulmonary Valve System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Artificial Pulmonary Valve System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Artificial Pulmonary Valve System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Artificial Pulmonary Valve System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Artificial Pulmonary Valve System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Artificial Pulmonary Valve System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Artificial Pulmonary Valve System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Pulmonary Valve System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Pulmonary Valve System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Artificial Pulmonary Valve System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Artificial Pulmonary Valve System Market Competition by Key Manufacturers

9.1. Global Artificial Pulmonary Valve System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Artificial Pulmonary Valve System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Edwards Lifesciences

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Abbott

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Terumo

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Valtech Cardio

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Epicor Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Venus Medtech Medical Device

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Pulmonary Valve System Market

Figure 4: Global Artificial Pulmonary Valve System Market: Drivers

Figure 5: Global Artificial Pulmonary Valve System Market: Challenges

Figure 6: Global Artificial Pulmonary Valve System Market: Trends

Figure 7: Global Artificial Pulmonary Valve System Market: Opportunity

Figure 8: Global Artificial Pulmonary Valve System Market: Restraint

Figure 9: Global Artificial Pulmonary Valve System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Artificial Pulmonary Valve System Market Value (USD Million) By Region

Figure 19: Global Artificial Pulmonary Valve System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Artificial Pulmonary Valve System Market Value (USD Million) By Region

Figure 27: Global Artificial Pulmonary Valve System Market Share (%) By: Regions (2032)

Figure 28: Global Artificial Pulmonary Valve System Market Volume (K) By Region

Figure 29: Global Artificial Pulmonary Valve System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Artificial Pulmonary Valve System Market Value (USD Million) By Region

Figure 37: Global Artificial Pulmonary Valve System Market Share (%) By: Regions (2032)

Figure 38: Global Artificial Pulmonary Valve System Market Volume (K) By Region

Figure 39: Global Artificial Pulmonary Valve System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Pulmonary Valve System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Pulmonary Valve System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Pulmonary Valve System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Artificial Pulmonary Valve System Market Value (USD Million) By Region

Table 14: Global Artificial Pulmonary Valve System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Artificial Pulmonary Valve System Market Volume (K) By Region

Table 31: Global Artificial Pulmonary Valve System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Artificial Pulmonary Valve System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Artificial Pulmonary Valve System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Artificial Pulmonary Valve System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Edwards Lifesciences Basic Information And Sales Area

Table 54: Edwards Lifesciences. Products Portfolio

Table 55: Boston Scientific Basic Information And Sales Area

Table 56: Boston Scientific. Products Portfolio

Table 57: Abbott Basic Information And Sales Area

Table 58: Abbott. Products Portfolio

Table 59: Terumo Basic Information And Sales Area

Table 60: Terumo. Products Portfolio

Table 61: Valtech Cardio Basic Information And Sales Area

Table 62: Valtech Cardio. Products Portfolio

Table 63: Epicor Medical Basic Information And Sales Area

Table 64: Epicor Medical. Products Portfolio

Table 65: Venus Medtech Medical Device Basic Information And Sales Area

Table 66: Venus Medtech Medical Device. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Artificial Pulmonary Valve System Market Value (USD Million) By Region

Table 76: Global Artificial Pulmonary Valve System Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Artificial Pulmonary Valve System Market Volume (K) By Region

Table 93: Global Artificial Pulmonary Valve System Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Artificial Pulmonary Valve System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Edwards Lifesciences; Boston Scientific; Abbott; Terumo; Valtech Cardio; Epicor Medical; Venus Medtech Medical Device
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for minimally invasive procedures is driving the adoption of Artificial Pulmonary Valve System, fueled by advancements in transcatheter technologies and improved patient outcomes.

Restraints2 items

High costs associated with Artificial Pulmonary Valve System procedures and devices are limiting their adoption, particularly in price-sensitive markets where affordability is a significant concern.

Stringent regulatory frameworks and the need for clinical trials to demonstrate safety and efficacy are creating barriers to entry for new players in the Artificial Pulmonary Valve System market.

Opportunities2 items

Challenges2 items

Ensuring the long-term durability and performance of Artificial Pulmonary Valve System devices is a key challenge, requiring ongoing research and development to improve device design and materials.

Market Segmentation

Loading chart…

Artificial Pulmonary Valve System Segmentation Breakdown9 items

Application

Pulmonary Valve Stenosis

Pulmonary Valve Regurgitation

Pulmonary Hypertension

Others

Types

PLA

PCL

Others

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: regional expansion

Edwards Lifesciences: innovation pipeline

Boston Scientific: premium pricing

Abbott: OEM tie-ups

Terumo: local manufacturing

Valtech Cardio: vertical integration

Key Artificial Pulmonary Valve System Companies8 items

Medtronic

Edwards Lifesciences

Boston Scientific

Abbott

Terumo

Valtech Cardio

Epicor Medical

Venus Medtech Medical Device

Market Ecosystem

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and assemble Artificial Pulmonary Valve Systems

Technology providers — develop enabling technologies

System integrators / EPCs — integrate systems and provide installation services

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents